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A
 
BSTRACT
 
The Ig-like receptors provide positive and negative
regulation of immune cells upon recognition of various
ligands, thus enabling those cells to respond ade-
quately to extrinsic stimuli. Murine paired Ig-like recep-
tor (PIR)-A and PIR-B, a typical receptor pair of the
Ig-like receptor family, are expressed on a wide range
of cells in the immune system, such as B cells, mast
cells, macrophages and dendritic cells, mostly in a
pair-wise fashion. The PIR-A requires the homodimeric
Fc receptor common 
 
γ
 
 chain for its efficient cell-surface
expression and for the delivery of activation signaling.
In contrast, PIR-B inhibits receptor-mediated activation
signaling 
 
in vitro
 
 upon engagement with other activating-
type receptors, such as the antigen receptor on B cells
and the high-affinity Fc receptor for IgE on mast cells.
Although the ligands for PIR-A and PIR-B remain
unknown, recent studies on PIR-B-deficient mice have
provided us with valuable insight into the physiological
significance of PIR-B, particularly in its regulatory role
in balancing the humoral immune response.
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I
 
NTRODUCTION
 
Paired immunoglobulin (Ig)-like receptors (PIR) were first
identified as those homologous to human Fc receptor
(FcR) for IgA, Fc
 
α
 
RI. In 1997, Hayami 
 
et al
 
.
 
1
 
 reported
the isolation of several cDNA clones coding for a novel
molecule from a B10.A mouse macrophage cDNA
library during the course of experiments to obtain a
hypothetical murine counterpart of Fc
 
α
 
RI. The gene
product was initially designated as p91 due to the
calculated molecular weight of the mature polypeptide
backbone.
 
1
 
 A similar approach by Kubagawa 
 
et al
 
.
 
2
 
yielded a novel gene family, the members of which
constitute a set of PIR-A and PIR-B genes in the BALB/c
splenic library (Fig. 1). Because p91 and PIR-B were the
most plausibly identical molecules based on their 98%
sequence identity, the nomenclature has been standard-
ized as PIR to avoid confusion.
 
3
 
These initial studies could not detect PIR binding to
IgA nor other Ig,
 
1,2
 
 suggesting that they are not recep-
tors for Ig. Instead, PIR-A and PIR-B are now proposed
as relatives or orthologs of human leukocyte Ig-like
receptors (LILR), based on their similarities in structure,
expression profiles and genomic localization.
 
1,2,4–6
 
 The
analogy of PIR-B to the inhibitory isoform of LILR,
namely LILRB, and the findings that constitutive phos-
phorylation of PIR-B in splenocytes was reduced in 
 
β
 
2
 
-
microglobulin (
 
β
 
2
 
m)-deficient mice
 
7
 
 led to the notion
that PIR-B may recognize classical or non-classical
major histocompatibility complex (MHC) class I mole-
cule(s).
 
6,7
 
 The observation that human histocompatibility
leukocyte antigen (HLA)-G, a non-classical MHC class
Ib on fetal trophoblast cells, binds PIR-B
 
8
 
 supports this
notion. However, there is no direct evidence for the
interaction between PIR and MHC class I molecules.
In the present review, the possible physiological sig-
nificance of PIR will be discussed with particular refer-
ence to results from recent studies on PIR-B-deficient
(PIR-B
 
–/–
 
) mice.
 
9
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S
 
TRUCTURAL
 
 
 
OVERVIEW
 
 
 
OF
 
 PIR
 
The PIR-A and PIR-B receptors are expressed on various
hematopoietic cell lineages, including B cells, mast cells,
macrophages, granulocytes and dendritic cells (DC),
mostly in a pair-wise fashion, but are not expressed on T
and natural killer (NK) cells (Fig. 1).
 
1,2,10
 
 Amino acid
sequences of PIR-A and PIR-B ectodomains are highly
homologous (over 92% identity).
 
1,2
 
 The deduced struc-
ture of PIR-B is a type I transmembrane glycoprotein with
six extracellular Ig-like domains, a hydrophobic trans-
membrane segment and an intracellular polypeptide
with four immunoreceptor tyrosine-based inhibitory
motifs (ITIM) or ITIM-like sequences (consensus: (I/L/V/
S)
 
X
 
Y
 
XX
 
(L/V); Fig. 1). The PIR-B is highly homologous to
the murine gp49B1 (31% homology at the amino acid
level),
 
11
 
 human killer Ig-like receptors (KIR; 34%),
 
12–15
 
the human Fc
 
α
 
RI (29%),
 
16
 
 the bovine Fc
 
γ
 
2R (32%)
 
17
 
 and
less homologous to human and mouse Fc
 
γ
 
RIIB (17%).
 
18
 
In contrast, PIR-A molecules have six Ig-like extra-
cellular domains, but contain unique pretransmembrane,
transmembrane and short cytoplasmic sequences har-
boring no ITIM-like motifs (Fig. 1). In addition, their
transmembrane domains contain a positively charged
residue, Arg, which presumably is crucial for the associa-
tion of the FcR common 
 
γ
 
 subunit (FcR
 
γ
 
), which itself is
critical for expression on the cell surface and for delivery
of the activation signal.
 
3,10,19,20
 
Although comparison of the available sequences of
PIR extracellular portions from 129/Sv, B10.A and
 
Fig. 1
 
Schematic structures of mouse and rat paired Ig-like receptor (PIR)-A and PIR-B and their close relatives, chicken CHIR
(chicken PIR homologs) and human leukocyte Ig-like receptors (LILR) and killer Ig-like receptors (KIR). Upper boxes show ligands for
them and bottom boxes show cellular distribution. Activating-type Ig-like receptors have a positively charged amino acid, Arg (R) or
His (H), in their transmembrane domains, which is involved in their interaction with negatively charged Asp (D) residues of FcR
 
γ
 
 or
DAP12 homodimer.
 
39,40
 
 In contrast, inhibitory Ig-like receptors have several immunoreceptor tyrosine-based inhibitory motifs (ITIM)
or ITIM-like sequences in their cytoplasmic portions important for SHP-1 recruitment upon tyrosine phosphorylation. GenBank
accession numbers for PIR: U83172, AF040946040953 and AF041035 and AF041036 (as p91) and U96682–96693. The
multiple 
 
PIR-A
 
 and single 
 
PIR-B
 
 genes locate near the centromeric region of mouse chromosome 7, syntenic to human LRC located
in 19q.13.4. Fluorescence 
 
in situ
 
 hybridization analysis of rat 
 
PIR
 
 genes identified the locus 1q21.1–21.3, which is syntenic to the
mouse chromosome 7 centromeric region.
 
5
 
 MHC, major histocompatibility complex. Repertoires of KIR and LILR are more compli-
cated than those illustrated here. For details for the KIR family, see http://www.ncbi.nlm.nih.gov/prow/guide/679664748_g.htm
and http://www.gene.ucl.ac.uk/nomenclature/genefamily/kir.html; for LILR, see http://www.gene.ucl.ac.uk/nomenclature/genefamily/
lilr.html
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BALB/c mice indicated a fairly high sequence similarity,
multiple substitutions of amino acid residues were observed,
especially in the first four extracellular domains.
 
2,5
 
 The
polymorphic nature of PIR may indicate that the ligand(s)
would also be polymorphic, similar to the situation for
LILR and KIR, which have many polymorphic substitutions
in their extracellular domains
 
12,21
 
 that recognize poly-
morphic MHC class I molecules. The 
 
PIR
 
 genes were
localized to the proximal end of the mouse chromosome
7,
 
5
 
 which is a syntenic position of human chromosome
19q13.3–13.4 harboring the leukocyte receptor cluster
(LRC). In LRC, 
 
LILR
 
 and 
 
KIR
 
 genes have been mapped,
 
4,22
 
supporting the notion that the 
 
PIR
 
 and 
 
LILR
 
 gene families
are close relatives or orthologs.
 
E
 
XPRESSION
 
 
 
AND
 
 
 
GENE
 
 
 
EVOLUTION
 
Monoclonal and polyclonal antibodies to PIR identified
cell-surface glycoproteins of approximately 85 and
120 kDa on B cells, granulocytes and macrophages.
 
10
 
Using a fibroblast transfection experiment as well as
FcR
 
γ
 
-deficient (FcR
 
γ
 
–/–
 
) mice, it was shown that approxi-
mately 120 kDa PIR-B is normally expressed on the cell
surface without any other subunits, whereas approxi-
mately 85 kDa PIR-A requires association with FcR
 
γ
 
 for
its cell surface expression.
 
3,10,19,20
 
 Interestingly, cell
surface levels of PIR molecules on myeloid and B lineage
cells increased with cellular differentiation and activa-
tion.
 
10
 
 Surface PIR levels are highest on marginal zone B
cells and the B1 B cells express higher PIR levels than the
B2 B cells.
 
10
 
Considering gene evolution of 
 
PIR
 
, it is interesting to
see PIR from other species. The LILR are human relatives
or orthologs of PIR. Structures of rat PIR-A and PIR-B
homologs
 
23
 
 (Fig. 1) were quite similar to those of respec-
tive mouse PIR, indicating that the structural hallmarks
of the 
 
PIR
 
 gene family are conserved in rats and mice.
Of note, analysis of mRNA detected unpaired expression
of rat PIR-A by B cells and rat PIR-B by NK cells, suggest-
ing divergence of PIR regulatory elements during rodent
speciation.
 
23
 
 Similarly, chicken PIR homologs (termed
CHIR) were identified
 
24,25
 
 (Fig. 1). Although the activating
type CHIR-A and inhibitory CHIR-B have only two Ig-like
domains in their extracellular portion, other structural
characteristics were similar to mouse and rat PIR-A and
PIR-B. A basic histidine residue was located in the CHIR-A
transmembrane region and two tyrosine residues embed-
ded in the ITIM consensus sequences were present in the
CHIR-B cytoplasmic portion. Coordinate expression of
CHIR-A and CHIR-B mRNA was observed in B and T cell
lines.
 
PIR-A 
 
ACTIVATION
 
 
 
SIGNALING
 
Engagement of transfected PIR-A expressed on the rat
mast cell line RBL-2H3 with antibodies elicited a calcium
mobilization and degranulation response, indicating that
PIR-A plays a role in the activation of mast cells.
 
3
 
 The
molecule associating with the PIR-A transmembrane
region was FcR
 
γ
 
10,19,20
 
 and the Fc
 
ε
 
RI
 
β
 
 chain in RBL-
2H3,
 
19
 
 in which two charged residues, Arg626 and
Glu643, were pivotal in the activating function of PIR-A
and its association with the FcR subunits.
 
19
 
 Events in the
downstream signaling of FcR
 
γ
 
 have been studied exten-
sively in relation to Fc
 
ε
 
RI on mast cells and Fc
 
γ
 
RI/III on
macrophages.
 
26
 
 However, the exact physiologic nature
of PIR-A/FcR
 
γ
 
 signaling has not been studied adequately
because of a lack of information regarding the ligand
for PIR-A.
 
I
 
NHIBITORY
 
 
 
SIGNAL
 
 
 
TRANSDUCTION
 
 
 
VIA
 
 PIR-B
 
Most of the inhibitory isoforms of Ig-like receptors exert
their negative regulation of cells by recruiting SH2-
containing tyrosine phosphatases SHP-1 and/or SHP-2
to their phosphorylated ITIM.
 
26–28
 
 Exceptionally, a
unique inhibitory Fc
 
γ
 
R, namely Fc
 
γ
 
RIIB, recruits SH2-
containing inositol 5-phosphatase SHIP-1 to the
phosphorylated ITIM.
 
26–28
 
 The PIR-B is demonstrated to
function by recruiting SHP-1 andSHP-2. 
 
In vitro
 
 mutation
analysis of cytoplasmic tyrosine residues in the ITIM of
PIR-B indicated that the tyrosine in the third ITIM plays
the most crucial role in mediating the inhibitory signal
for B cell receptor (BCR)-mediated cell activation as
assessed by calcium mobilization and activation of
nuclear factor of activated T cells (NF-AT).
 
29
 
 Also 
 
in vitro
 
,
synthetic phosphotyrosyl peptides corresponding to the
third and fourth ITIM of PIR-B can bind SHP-1, SHP-2
and SHIP-1 in cell extracts from macrophages, as well as
in a B cell line.
 
5
 
 However, the PIR-B-mediated inhibition
was markedly reduced in SHP-1 and SHP-2 double-
deficient DT40 chicken B cells, whereas this inhibition
was unaffected in SHIP-deficient cells, strongly suggest-
ing that PIR-B can negatively regulate BCR activation
by redundant functions of SHP-1 and SHP-2, but not by
SHIP-1
 
29
 
 (Fig. 2). In addition, in the mast cell line
RBL-2H3, coaggregation of transfected PIR-B with FcεRI
induced the PIR-B to recruit SHP-1 but not SHP-2 or
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SHIP.30 Even in the absence of the coaggregation, weak
constitutive association of the PIR-B cytoplasmic domain
with SHP-1 was observed.30 The third and fourth ITIM
tyrosine residues were crucial for inhibition of RBL-2H3
cell degranulation and calcium mobilization.3
A reverse approach yielded an interesting observation
about the preferential association of SHP-1 to PIR-B. The
SHP-1 was shown to associate with a 130 kDa tyrosyl-
phosphorylated species, namely P130, in murine macro-
phages, suggesting that the P130 may be an SHP-1 reg-
ulator and/or substrate.31 Interestingly, P130 consisted of
two transmembrane glycoproteins, namely PIR-B and the
signal-regulatory protein (SIRP) family member brain
immunoglobulin-like molecule with tyrosine-based
activation motifs (BIT). Furthermore, PIR-B was hyper-
phosphorylated in macrophages from SHP-1-inactive
motheaten viable mice, whereas it was hypophosphory-
lated in SHP-1-deficient motheaten macrophages,
suggesting a model in which SHP-1 dephosphorylates
specific sites on PIR-B while protecting other sites from
dephosphorylation via its SH2 domains.31 The PIR-B also
associates with two tyrosyl phosphoproteins and a tyro-
sine kinase activity.31
Irrespective of the cell activation status, PIR-B mole-
cules in macrophages and B cells are constitutively phos-
phorylated and PIR-B in splenocytes was constitutively
associated with SHP-1 and Lyn.7 In Lyn-deficient mice,
PIR-B tyrosine phosphorylation was greatly reduced.7 The
ligation of PIR-B on chicken DT40 cells inhibits the BCR-
induced tyrosine phosphorylation of Igα/Igβ, Syk, Btk and
PLC-γ232 (Fig. 2). The constitutive association of SHP-1
with PIR-B suggests that the inhibitory function of PIR-B
may not necessarily require coligation of BCR and PIR-B
by any ligand (Fig. 2). This speculation was shown to be
the case in splenic B cells from PIR-B–/– mice, as described
below.
PHYSIOLOGICAL ROLE OF PIRS
Human PIR relatives, the LILR, which share 50–60%
sequence similarity with PIR, bind classical or non-
classical MHC class I alleles.21,33,34 Constitutive tyrosine
phosphorylation and constitutive association with the
SHP-1 and Lyn protein tyrosine kinase imply that the
PIR-B molecules are constitutively ligated with self ligands,
such as MHC class I.7 The PIR-B tyrosine phosphory-
lation status was examined in β2m-deficient, transporter
associated with antigen presentation 1 (TAP1)-deficient
and MHC class II-deficient mice. The level of PIR-B
tyrosine phosphorylation is reduced by approximately
50% in β2m-deficient mice, but is not significantly altered
in TAP1- or MHC class II-deficient mice, suggesting that
non-classical MHC class I or class I-like molecules are
more likely candidates for native PIR ligands.7 Although
the ligand(s) for PIR is, at present, unidentified, the PIR
may modulate inflammatory and immune responses by
constitutive engagement with the putative ligand(s).9
Recent PIR-B–/– mice have provided us with insight into
the physiological significance of PIR in the immune
response, especially in humoral immunity.9
DOMINANT EXPRESSION OF PIR-B
Because an available monoclonal antibody to PIR,
namely 6C1, recognizes both PIR-A and PIR-B, it was not
known which receptor is dominantly expressed on
various cell surfaces. Given that the deletion of one
receptor does not influence the expression of the other,
PIR-B deficiency will tell us the surface expression of
PIR-A by flow cytometry with 6C1, whereas cells devoid
Fig. 2 Positive and negative signaling via paired Ig-like recep-
tors (PIR). Left, PIR-A on mast cells is expressed as a complex
with an FcRγ homodimer and FcεRIβ subunit, which have
immunoreceptor tyrosine-based activation motifs (ITAM). Cross-
linking of PIR-A induces a calcium mobilization and degranula-
tion response via these FcR subunits. Surface expression of
PIR-A on mast cells is much less abundant than PIR-B in vivo.9
Right, schematic illustration of negative signaling via PIR-B upon
constitutive stimulation by a putative ligand. Lyn and SHP-1
were constitutively associated with the tyrosine-phosphorylated
cytoplasmic portion of PIR-B in B cells and macrophages,7
suggesting that it is not necessary to induce cross-linking
between B cell receptor (BCR) and PIR-B for the inhibitory effect
in vivo. In fact, in PIR-B–/– B cells, BCR is hyperresponsive to anti-
BCR stimulation.9
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of FcRγ will enable us to estimate PIR-B expression.
Comparison of flow cytometric data on cells from either
PIR-B–/–9 or FcRγ–/– mice36 revealed the more dominant
expression of PIR-B than PIR-A on splenic macrophages,
splenic DC and bone marrow-derived cultured mast
cells and exclusive expression of PIR-B on splenic B cells.
The consistent observations from either PIR-B or FcRγ
deletion suggested that the PIR-B deletion did not largely
alter PIR-A expression in these cells and vice versa. Thus,
PIR-A and PIR-B surface expression is characteristic for
each cell type, at least in its resting state, and the
suppression of these cells by dominantly expressed PIR-B
may have a physiological importance, such as in main-
taining their resting state.
PIR-B–/–B CELLS ARE HYPERRESPONSIVE
The PIR-B molecules in macrophages and B cells are
constitutively phosphorylated.7 Thus, deletion of PIR-B
may induce B cell hypersensitivity upon BCR ligation,
similar to that seen in CD22-deficient mice.36,37 In fact,
PIR-B–/– splenic B cells showed significantly enhanced
proliferation upon anti-BCR F(ab‘)2 stimulation. When
stimulated with anti-BCR whole IgG antibodies after
blocking with anti-FcγRIIB monoclonal antibody, the
enhanced PIR-B–/– B cell proliferation was more pro-
nounced due to masking of an inhibitory effect by
FcγRIIB. This indicates that the inhibitory effects by PIR-B
and FcγRIIB are additive, possibly because of the fact
that PIR-B uses the SHP-1 cascade for inhibition whereas
FcγRIIB uses SHIP.9 These results indicate that PIR-B–/–
B cells are hypersensitive to stimulation via BCR ligation.
Consistent with this observation, PIR-B–/– mice showed a
higher IgM response against T-independent antigens
trinitrophenyl (TNP)-Ficoll and TNP-lipopolysaccharide
(LPS).9 The enhanced response upon TNP-LPS challenge
suggested that the PIR-B inhibitory effect could also be
exerted independently of BCR ligation. Enhanced tyro-
sine phosphorylation of cellular proteins in PIR-B–/–
B cells even in the resting state indicated the constitutive
activation of PIR-B–/– B cells.9 Thus, PIR-B may downreg-
ulate BCR signaling by interacting with any unidentified
ligand. A PIR-B deficiency may generally render B cells
active and hyperresponsive to stimulation via BCR.
However, serum IgM levels were not increased in naïve
PIR-B–/– mice. In addition, antidouble-stranded DNA
antibodies were not detected in adult PIR-B–/– mice, in
contrast with CD22-deficient mice, in which hyper-IgM
and autoantibody production is evident.36,37
PIR-B DEFICIENCY LEADS TO TH2-SKEWED 
RESPONSE
The Th2-prone humoral responses were augmented in
PIR-B–/– mice upon immunization with T-dependent
antigens in terms of both interleukin (IL)-4-rich and
interferon-γ-poor cytokine profiles and enhanced IgG1
and IgE production.9 At least one of the mechanisms for
the Th2-skewed responses in PIR-B–/– mice was the
immature phenotype of DC (Fig. 3). Flow cytometric
analysis of surface markers, such as MHC class II, CD80
and CD86, on bone marrow-derived cultured DC
before and after antigen loading revealed that the
DC from PIR-B–/– mice were immature. The production
of IL-12, a Th1-polarizing cytokine,38 was greatly dimin-
ished upon antigen loading of DC from PIR-B–/– mice.
Successful adoptive transfer of a Th2-prone response
by PIR-B–/– DC into wild-type mice demonstrated that
the impaired maturation of DC was responsible for the
skewing.
What is the mechanism for the impaired maturation of
DC in PIR-B deficiency? To test the possibility that intra-
cellular signaling may differ between PIR-B–/– DC and
wild-type cells, bone marrow DC were stimulated with
granulocyte–macrophage colony stimulating factor
(GM-CSF), an inducer cytokine for DC development,
and were examined for their protein tyrosine phosphory-
lation profile.9 The PIR-B was tyrosine phosphorylated
in resting wild-type DC similar to that found in resting
Fig. 3 Possible mechanism for the Th2-skewed humoral re-
sponse in paired Ig-like receptor (PIR)-B–/– mice. Granulocyte–
macrophage colony stimulating factor-induced dendritic cells
(DC) from PIR-B–/– bone marrow cells show immature phenotype
in terms of their lower expression of major histocompatibility
complex class II, CD80 and CD86 and lower interleukin (IL)-12
production after antigen loading. Because IL-12 is a Th1-
polarizing cytokine, its less-abundant production by DC will lead
to poor naive T (T0) to Th1 differentiation and, as a result,
Th2-prone differentiation could occur. wt, wild type; CTL, cyto-
toxic T lymphocyte.
98 T TAKAI
B cells.7 The tyrosine phosphorylation of PIR-B was aug-
mented upon GM-CSF stimulation, indicating that PIR-B
is involved in the cytokine signaling. After GM-CSF
stimulation, the GM-CSF receptor common β chain was
tyrosine phosphorylated, but the time-course of the phos-
phorylation in PIR-B–/– DC was more transient than that in
wild-type cells. Thus, PIR-B deficiency leads to altered
phosphorylation profiles of GM-CSF signaling, which
yields immature DC. Thus, analysis of PIR-B–/– mice
indicated that PIR-B is critical for B cell suppression, DC
maturation and for balancing Th1 and Th2 immune
responses.
FUTURE PIR RESEARCH
Collectively, identification of the ligand(s) for PIR-A and
PIR-B and its characterization should be the next step.
Given that the classical or non-classical MHC class I
molecules could, in fact, interact with PIR-B, then PIR-B
should be a novel, ubiquitously expressed negative regu-
lator for immune cells, such as B cells and DC. Various
immune cells may have adopted recognition of self-MHC
class I molecules as a common strategy to inhibit cellular
activation. Further analysis of PIR-B–/– mice will provide us
with much more information about the physiological role
of PIR-B and pathophysiological aspects of its involvement
in infection, hypersensitivity and autoimmune diseases.
Similarly, we should make more detailed analysis of
FcRγ–/– mice in terms of the influence of loss of PIR-A
expression. The FcRγ–/– mice exhibit pleiotrophic effector
cell defects in IgG- or IgE-mediated immune responses,35
such as the disappearance of the phagocytic activity of
macrophages and unresponsiveness to IgE-mediated
hypersensitive responses due to the loss of FcεRI and
FcγRI/III expression, but we do not know whether the
phenotypes of FcRγ–/– mice involve the effect of PIR-A
deficiency or not. Detailed analysis of FcRγ–/– mice may
suggest a possible ‘activating’ function of PIR-A in light of
the speculation that PIR-B is a constitutive inhibitor for
many cells in the immune system.
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